Cargando…

An enhanced genetic model of relapsed IGH-translocated multiple myeloma evolutionary dynamics

Most patients with multiple myeloma (MM) die from progressive disease after relapse. To advance our understanding of MM evolution mechanisms, we performed whole-genome sequencing of 80 IGH-translocated tumour-normal newly diagnosed pairs and 24 matched relapsed tumours from the Myeloma XI trial. We...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hoang, Phuc H., Cornish, Alex J., Sherborne, Amy L., Chubb, Daniel, Kimber, Scott, Jackson, Graham, Morgan, Gareth J., Cook, Gordon, Kinnersley, Ben, Kaiser, Martin, Houlston, Richard S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7560599/ https://www.ncbi.nlm.nih.gov/pubmed/33057009 http://dx.doi.org/10.1038/s41408-020-00367-2

Ejemplares similares

Impact of mitochondrial DNA mutations in multiple myeloma
por: Hoang, Phuc H., et al.
Publicado: (2020)

Whole-genome sequencing of multiple myeloma reveals oncogenic pathways are targeted somatically through multiple mechanisms
por: Hoang, Phuc H., et al.
Publicado: (2018)

Mutational processes contributing to the development of multiple myeloma
por: Hoang, Phuc H., et al.
Publicado: (2019)

Undefined familial colorectal cancer and the role of pleiotropism in cancer susceptibility genes
por: Dobbins, Sara E., et al.
Publicado: (2016)

Imaging flow cytometry-based multiplex FISH for three IGH translocations in multiple myeloma
por: Tsukamoto, Taku, et al.
Publicado: (2023)

Reference bias in the Illumina Isaac aligner
por: Cornish, Alex J, et al.
Publicado: (2020)

Cancer drivers and clonal dynamics in acute lymphoblastic leukaemia subtypes
por: Studd, James B., et al.
Publicado: (2021)

Copy number evolution and its relationship with patient outcome—an analysis of 178 matched presentation-relapse tumor pairs from the Myeloma XI trial
por: Croft, James, et al.
Publicado: (2020)

Double-Hit Primary Plasma Cell Leukemia with IGH/MYC and IGH/CCND1 Translocations
por: Yasumi, Masato, et al.
Publicado: (2020)

Predicting ultrahigh risk multiple myeloma by molecular profiling: an analysis of newly diagnosed transplant eligible myeloma XI trial patients
por: Shah, Vallari, et al.
Publicado: (2020)

Multiple mechanisms can disrupt oncogenic pathways in multiple myeloma
por: Hoang, Phuc H., et al.
Publicado: (2018)

Long-range Oncogenic Activation of IgH/c-myc Translocations by the IgH 3’ Regulatory Region
por: Gostissa, Monica, et al.
Publicado: (2009)

Exploiting gene dependency to inform drug development for multiple myeloma
por: Went, Molly, et al.
Publicado: (2022)

Genetic Predisposition to Multiple Myeloma at 5q15 Is Mediated by an ELL2 Enhancer Polymorphism
por: Li, Ni, et al.
Publicado: (2017)

Long-read sequencing unveils IGH-DUX4 translocation into the silenced IGH allele in B-cell acute lymphoblastic leukemia
por: Tian, Liqing, et al.
Publicado: (2019)

P964: IMMUNOPHENOTYPED-SUSPENSION-MULTIPLEX FISH BY IMAGING FLOW CYTOMETRY FOR THE SIMULTANEOUS DIAGNOSIS OF THREE PIVOTAL IGH TRANSLOCATIONS IN MULTIPLE MYELOMA
por: Tsukamoto, T., et al.
Publicado: (2022)

Clonal evolution in myeloma: the impact of maintenance lenalidomide and depth of response on the genetics and sub-clonal structure of relapsed disease in uniformly treated newly diagnosed patients
por: Jones, John R., et al.
Publicado: (2019)

APOBEC family mutational signatures are associated with poor prognosis translocations in multiple myeloma
por: Walker, Brian A, et al.
Publicado: (2015)

Genomic Architecture may Influence Recurrent Chromosomal Translocation Frequency in the Igh Locus
por: Kenter, Amy L., et al.
Publicado: (2013)

Ixazomib with cyclophosphamide and dexamethasone in relapsed or refractory myeloma: MUKeight phase II randomised controlled trial results
por: Auner, Holger W., et al.
Publicado: (2022)

Anaplastic multiple myeloma with amplification of the IGH-CCND1 gene fusion
por: Alencar, Rafael Nobrega, et al.
Publicado: (2023)

IGH Translocations in Chinese Patients With Chronic Lymphocytic Leukemia: Clinicopathologic Characteristics and Genetic Profile
por: Li, Qinlu, et al.
Publicado: (2022)

Enhancer RNA AL928768.3 from the IGH Locus Regulates MYC Expression and Controls the Proliferation and Chemoresistance of Burkitt Lymphoma Cells with IGH/MYC Translocation
por: Stasevich, Ekaterina Mikhailovna, et al.
Publicado: (2022)

Search for rare protein altering variants influencing susceptibility to multiple myeloma
por: Scales, Matthew, et al.
Publicado: (2017)

Implementation of genome-wide complex trait analysis to quantify the heritability in multiple myeloma
por: Mitchell, Jonathan S., et al.
Publicado: (2015)

The relative importance of factors predicting outcome for myeloma patients at different ages: results from 3894 patients in the Myeloma XI trial
por: Pawlyn, Charlotte, et al.
Publicado: (2019)

A role for AID in chromosome translocations between c-myc and the IgH variable region
por: Dorsett, Yair, et al.
Publicado: (2007)

A role for AID in chromosome translocations between c-myc and the IgH variable region
por: Dorsett, Yair, et al.
Publicado: (2007)

Recurrent Novel P2RY8/IGH Translocations in B-Lymphoblastic Leukemia/Lymphoma
por: Fang, Yanglan, et al.
Publicado: (2022)

Sex Differences in Multiple Myeloma Biology but not Clinical Outcomes: Results from 3894 Patients in the Myeloma XI Trial
por: Bird, Sarah, et al.
Publicado: (2021)

Dutcher bodies in an IgA‐myeloma patient harbouring the FGFR3/IGH fusion
por: Manabe, Masahiro, et al.
Publicado: (2023)

Inhibition of cell cycle progression by dual phosphatidylinositol-3-kinase and mTOR blockade in cyclin D2 positive multiple myeloma bearing IgH translocations
por: Glassford, J, et al.
Publicado: (2012)

Extranodal marginal zone lymphoma of the dura mater with IgH/MALT1 translocation and review of literature
por: Bhagavathi, Sharathkumar, et al.
Publicado: (2008)

Searching for causal relationships of glioma: a phenome-wide Mendelian randomisation study
por: Saunders, Charlie N., et al.
Publicado: (2020)

Combination venetoclax and selinexor effective in relapsed refractory multiple myeloma with translocation t(11;14)
por: Nguyen, Nina, et al.
Publicado: (2022)

What are genome-wide association studies telling us about B-cell tumor development?
por: Sherborne, Amy L, et al.
Publicado: (2010)

Chromosome 1q21 abnormalities refine outcome prediction in patients with multiple myeloma - a meta-analysis of 2,596 trial patients
por: Weinhold, Niels, et al.
Publicado: (2021)

Autologous stem cell transplantation is safe and effective for fit, older myeloma patients: exploratory results from the Myeloma XI trial
por: Pawlyn, Charlotte, et al.
Publicado: (2020)

Relationship between genetically determined telomere length and glioma risk
por: Saunders, Charlie N, et al.
Publicado: (2021)

Submicroscopic Deletions of Immunoglobulin Heavy Chain Gene (IGH) in Precursor B Lymphoblastic Leukemia with IGH Rearrangements
por: Huh, Jungwon, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_ubbjnvlb6bk4mm74hnf399bd86